Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID I)
Phase of Trial: Phase I
Latest Information Update: 07 Sep 2015
At a glance
- Drugs Valaciclovir (Primary)
- Indications Cytomegalovirus infections; Herpes simplex virus infections; Varicella zoster virus infections
- Focus Pharmacokinetics
- Acronyms VALID-I
- 02 Sep 2015 Status changed from suspended to completed as reported by ClinicalTrials.gov record.
- 28 Aug 2013 Planned End Date changed from 1 Feb 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 28 Aug 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.